RESUMEN
Despite data showing that nutritional interventions high in antioxidant/anti-inflammatory properties (anthocyanin-rich foods, such as blueberries/elderberries) may decrease risk of memory loss and cognitive decline, evidence for such effects in mild cognitive impairment (MCI) is limited. This study examined preliminary effects of American elderberry (Sambucus nigra subsp. canadensis) juice on cognition and inflammatory markers in patients with MCI. In a randomized, double-blind, placebo-controlled trial, patients with MCI (n = 24, Mage = 76.33 ± 6.95) received American elderberry (n = 11) or placebo (n = 13) juice (5 mL orally 3 times a day) for 6 months. At baseline, 3 months, and 6 months, patients completed tasks measuring global cognition, verbal memory, language, visuospatial cognitive flexibility/problem solving, and memory. A subsample (n = 12, 7 elderberry/5 placebo) provided blood samples to measure serum inflammatory markers. Multilevel models examined effects of the condition (elderberry/placebo), time (baseline/3 months/6 months), and condition by time interactions on cognition/inflammation outcomes. Attrition rates for elderberry (18%) and placebo (15%) conditions were fairly low. The dosage compliance (elderberry-97%; placebo-97%) and completion of cognitive (elderberry-88%; placebo-87%) and blood-based (elderberry-100%; placebo-100%) assessments was high. Elderberry (not placebo) trended (p = 0.09) towards faster visuospatial problem solving performance from baseline to 6 months. For the elderberry condition, there were significant or significantly trending decreases over time across several markers of low-grade peripheral inflammation, including vasorin, prenylcysteine oxidase 1, and complement Factor D. Only one inflammatory marker showed an increase over time (alpha-2-macroglobin). In contrast, for the placebo, several inflammatory marker levels increased across time (L-lactate dehydrogenase B chain, complement Factor D), with one showing deceased levels over time (L-lactate dehydrogenase A chain). Daily elderberry juice consumption in patients with MCI is feasible and well tolerated and may provide some benefit to visuospatial cognitive flexibility. Preliminary findings suggest elderberry juice may reduce low-grade inflammation compared to a placebo-control. These promising findings support the need for larger, more definitive prospective studies with longer follow-ups to better understand mechanisms of action and the clinical utility of elderberries for potentially mitigating cognitive decline.
Asunto(s)
Cognición , Disfunción Cognitiva , Jugos de Frutas y Vegetales , Inflamación , Sambucus , Humanos , Masculino , Anciano , Femenino , Cognición/efectos de los fármacos , Inflamación/sangre , Método Doble Ciego , Sambucus/química , Anciano de 80 o más Años , Biomarcadores/sangre , Estudios de Factibilidad , Sambucus nigra/químicaRESUMEN
As our population ages, there is interest in delaying or intervening in cognitive decline. While newer agents are under development, agents in mainstream use do not impact the course of diseases that cause cognitive decline. This increases interest in alternative strategies. Even as we welcome possible new disease-modifying agents, they are likely to remain costly. Herein, we review the evidence behind other complementary and alternative strategies for cognitive enhancement and prevention of cognitive decline.
Asunto(s)
Enfermedad de Alzheimer , Disfunción Cognitiva , Terapias Complementarias , Humanos , Enfermedad de Alzheimer/terapia , Trastornos Neurocognitivos , Disfunción Cognitiva/terapiaRESUMEN
Neurocognitive and sleep problems are common, underdiagnosed, and frequently co-morbid. Sleep disruption, and fatigue, predict cognitive impairment. Cognitive impairment, in turn, can worsen sleep hygiene. In dementia patients, sleep disorders are common, and dementia medications affect sleep. Emerging insights on the brain's glymphatic system suggests that sleep may drive clearance of Aß peptide to affect Alzheimer pathophysiology. Parkinsonian dementias are linked with REM behavior disorder, a highly treatable problem that predicts future conversion into dementia.
Asunto(s)
Disfunción Cognitiva/diagnóstico , Demencia/diagnóstico , Trastornos del Sueño-Vigilia/complicaciones , Péptidos beta-Amiloides/metabolismo , Disfunción Cognitiva/complicaciones , Disfunción Cognitiva/epidemiología , Demencia/etiología , Demencia/fisiopatología , Humanos , Pruebas Neuropsicológicas/normas , Trastornos Parkinsonianos/etiología , Fragmentos de Péptidos/metabolismo , Trastorno de la Conducta del Sueño REM/complicaciones , Trastorno de la Conducta del Sueño REM/fisiopatología , Trastornos del Sueño-Vigilia/diagnóstico , Trastornos del Sueño-Vigilia/epidemiologíaRESUMEN
We investigated the nature of covertly processed visual elements in a patient with simultanagnosia, a disorder characterized by the inability to perceive multiple aspects of a visual scene all at once. Using the first letter of the color words red, green, or blue, we created a novel testing paradigm that combined Navon global-local stimuli with a single-letter Stroop task. The letters R, G, or B were arranged in the overall configuration of a large R, G, or B. The patient never could report seeing the larger letter, and always could name the smaller letters. But, when asked to name ink color only, and ignore letter identity, the large letter covertly affected responding. That is, when the large letter was the same as the first letter of the ink color, the patient named ink color more quickly and accurately than when the large letter was incongruent with the correct response. Moreover, when the covert global and overt local visual processing conflicted, the global letter always dominated over the local letters, despite the patient's inability to perceive it consciously. These data show that the covert processing of global visual information in simultanagnosia can dominate overt local information, even across different streams of information processing.
Asunto(s)
Agnosia/diagnóstico , Percepción Visual/fisiología , Anciano , Femenino , Humanos , Reconocimiento Visual de Modelos/fisiologíaRESUMEN
Patient NS is a 28year-old female who went blind in her early twenties as a result of S-cone syndrome, a degenerative retinal disorder. A few years after losing her vision, she started experiencing visual perceptions of her hands as she moved them and objects that came into contact with her hands. Over the course of a year, these cross-modal sensations evolved to become veridical visual experiences accurately representative of her hands, objects she touched, and to some degree, objects she could infer from her immediate surroundings. We argue that these experiences are distinct from mental imagery as they occurred automatically, remained consistent over time, and were proprioceptively mediated by her head position much like normal optical vision. Moreover, she could neither consciously force these visual experiences to occur without sensory inference nor prevent them from happening when haptically exploring an object. Her previous visual experiences contributed to a strong influence of top-down processing in her perceptions. Though individuals have previously been able to develop limited veridical acquired synesthesia following extensive practice over many years with the use of a special sensory device, none reported experiencing the richness of complexity or degree of top-down processing exhibited by NS. Thus, we posit that NS's case may represent a phenomenon beyond synesthesia altogether.
Asunto(s)
Ceguera/fisiopatología , Trastornos de la Percepción/fisiopatología , Percepción del Tacto/fisiología , Adulto , Femenino , Humanos , SinestesiaRESUMEN
BACKGROUND: Informal caregivers of people with dementia frequently experience chronic insomnia, contributing to stress and poor health outcomes. Rural caregivers are particularly vulnerable but have limited access to cognitive behavioral therapy for insomnia (CBT-I), a recommended frontline treatment for chronic insomnia. Web-based delivery promises to improve insomnia, particularly for rural caregivers who have limited access to traditional in-person treatments. Our team translated an efficacious 4-session standard CBT-I content protocol into digital format to create NiteCAPP. OBJECTIVE: This study aimed to (1) adapt NiteCAPP for dementia caregivers to create NiteCAPP CARES, a tailored digital format with standard CBT-I content plus caregiver-focused modifications; (2) conduct usability testing and evaluate acceptability of NiteCAPP CARES' content and features; and (3) pilot-test the adapted intervention to evaluate feasibility and preliminary effects on sleep and related health outcomes. METHODS: We followed Medical Research Council recommendations for evaluating complex medical interventions to explore user needs and adapt and validate content using a stepwise approach: (1) a rural dementia caregiver (n=5) and primary care provider (n=5) advisory panel gave feedback that was used to adapt NiteCAPP; (2) caregiver (n=5) and primary care provider (n=7) focus groups reviewed the newly adapted NiteCAPP CARES and provided feedback that guided further adaptations; and (3) NiteCAPP CARES was pilot-tested in caregivers (n=5) for feasibility and to establish preliminary effects. Self-report usability measures were collected following intervention. Before and after treatment, 14 daily electronic sleep diaries and questionnaires were collected to evaluate arousal, health, mood, burden, subjective cognition, and interpersonal processes. RESULTS: The stepped approach provided user and expert feedback on satisfaction, usefulness, and content, resulting in a new digital CBT-I tailored for rural dementia caregivers: NiteCAPP CARES. The advisory panel recommended streamlining content, eliminating jargon, and including caregiver-focused content. Focus groups gave NiteCAPP CARES high usefulness ratings (mean score 4.4, SD 0.79, scored from 1=least to 5=most favorable; score range 4.2-4.8). Multiple features were evaluated positively, including the intervention's comprehensive and engaging information, caregiver focus, good layout, easy-to-access intervention material, and easy-to-understand sleep graphs. Suggestions for improvement included the provision of day and night viewing options, collapsible text, font size options, tabbed access to videos, and a glossary of terms. Pilot-test users rated usefulness (mean score 4.3, SD 0.83; range 4.1-4.5) and satisfaction (mean score 8.4, SD 1.41, scored from 1=least to 10=most satisfied; range 7.4-9.0) highly. Preliminary effects on caregiver sleep, arousal, health, mood, burden, cognition, and interpersonal processes (all P<.05) were promising. CONCLUSIONS: Adaptations made to standard digital CBT-I created a feasible, tailored digital intervention for rural dementia caregivers. Important next steps include further examination of feasibility and efficacy in a randomized controlled trial with an active control condition, a multisite effectiveness trial, and eventual broad dissemination. TRIAL REGISTRATION: ClinicalTrials.gov NCT04632628; https://clinicaltrials.gov/ct2/show/NCT04632628.
RESUMEN
BACKGROUND: A large number of individual potentially modifiable factors are associated with risk for Alzheimer's disease (AD). However, less is known about the interactions between the individual factors. METHODS: In order to begin to examine the relationship between a pair of factors, we performed a pilot study, surveying patients with AD and controls for stress exposure and dietary omega-3 fatty acid intake to explore their relationship for risk of AD. RESULTS: For individuals with the greatest stress exposure, omega-3 fatty acid intake was significantly greater in healthy controls than in AD patients. There was no difference among those with low stress exposure. CONCLUSIONS: These initial results begin to suggest that omega-3 fatty acids may mitigate AD risk in the setting of greater stress exposure. This will need to be examined with larger populations and other pairs of risk factors to better understand these important relationships. Examining how individual risk factors interact will ultimately be important for learning how to optimally decrease the risk of AD.
Asunto(s)
Enfermedad de Alzheimer , Ácidos Grasos Omega-3 , Fármacos Neuroprotectores , Humanos , Enfermedad de Alzheimer/prevención & control , Enfermedad de Alzheimer/complicaciones , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/uso terapéutico , Proyectos Piloto , Ácidos Grasos Omega-3/farmacología , Dieta , Ácidos GrasosRESUMEN
OBJECTIVE: The purpose of this study was to determine whether vagus nerve stimulation influences cognitive flexibility and creativity. METHODS: Ten subjects, in whom vagus nerve stimulators had been implanted for the treatment of intractable seizures, performed tasks that assessed cognitive flexibility (solving anagrams), creativity (Torrance Test), and memory (Hopkins Verbal Learning Test) during actual and sham vagus nerve stimulation. RESULTS: Vagus nerve stimulation impaired cognitive flexibility and creativity, but these results could not be explained by the induction of a general encephalopathy because VNS did not impair learning and improved retention. CONCLUSIONS: The means by which vagus nerve stimulation impairs cognitive flexibility and creative thinking is probably related to increased activity of the locus coeruleus-central adrenergic system that increases the signal-to-noise ratio and improves the brain's ability to attend to sensory input, but decreases its ability to recruit large-scale networks.
Asunto(s)
Cognición/fisiología , Creatividad , Terapia por Estimulación Eléctrica/efectos adversos , Epilepsias Parciales/psicología , Memoria/fisiología , Nervio Vago/fisiología , Adulto , Epilepsias Parciales/terapia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pruebas PsicológicasRESUMEN
BACKGROUND: Vagus nerve stimulation (VNS) has been shown to improve memory. OBJECTIVE: The purpose of this study was to learn at which stage of memory formation this influence occurs. METHODS: Ten subjects who had been implanted with vagus nerve stimulators for the treatment of intractable seizures performed tasks that assessed learning and retention (Hopkins Verbal Learning Test) during actual and sham VNS. RESULTS: We found that VNS had no effect on learning but enhanced consolidation, which led to improved retention. CONCLUSIONS: The means by which VNS improves retention is probably related to the increased activity in the nucleus of the tractus solitarius and the locus coeruleus-central adrenergic system that activates the amygdala and increases long-term potentiation in the hippocampus.